JPS52108970A - Production of novel aminoalkyl heterocyclic compound - Google Patents

Production of novel aminoalkyl heterocyclic compound

Info

Publication number
JPS52108970A
JPS52108970A JP2532377A JP2532377A JPS52108970A JP S52108970 A JPS52108970 A JP S52108970A JP 2532377 A JP2532377 A JP 2532377A JP 2532377 A JP2532377 A JP 2532377A JP S52108970 A JPS52108970 A JP S52108970A
Authority
JP
Japan
Prior art keywords
production
heterocyclic compound
novel aminoalkyl
aminoalkyl heterocyclic
novel
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2532377A
Other languages
English (en)
Inventor
Mentoruupu Anton
Shiyuromu Kuruto
Otsutoo Rento Erunshiyuto
Reifuru Rikaruto
Toraunekaa Uerunaa
Hoefuke Uorufuganku
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
CH Boehringer Sohn AG and Co KG
Original Assignee
CH Boehringer Sohn AG and Co KG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by CH Boehringer Sohn AG and Co KG filed Critical CH Boehringer Sohn AG and Co KG
Publication of JPS52108970A publication Critical patent/JPS52108970A/ja
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20—Oxygen atoms
    • C07D215/22—Oxygen atoms attached in position 2 or 4
    • C07D215/227—Oxygen atoms attached in position 2 or 4 only one oxygen atom which is attached in position 2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/28—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/30—Oxygen or sulfur atoms
    • C07D233/32—One oxygen atom
    • C07D233/36—One oxygen atom with hydrocarbon radicals, substituted by nitrogen atoms, attached to ring nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/24—Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • C07D235/26—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/52—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings condensed with carbocyclic rings or ring systems
    • C07D263/54—Benzoxazoles; Hydrogenated benzoxazoles
    • C07D263/58—Benzoxazoles; Hydrogenated benzoxazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/28—1,4-Oxazines; Hydrogenated 1,4-oxazines
    • C07D265/34—1,4-Oxazines; Hydrogenated 1,4-oxazines condensed with carbocyclic rings
    • C07D265/36—1,4-Oxazines; Hydrogenated 1,4-oxazines condensed with carbocyclic rings condensed with one six-membered ring

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Psychiatry (AREA)
  • Cardiology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Quinoline Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Laminated Bodies (AREA)
  • Nonwoven Fabrics (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
JP2532377A 1976-03-09 1977-03-08 Production of novel aminoalkyl heterocyclic compound Pending JPS52108970A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19762609645 DE2609645A1 (de) 1976-03-09 1976-03-09 Aminoalkylheterocyclen

Publications (1)

Publication Number Publication Date
JPS52108970A true JPS52108970A (en) 1977-09-12

Family

ID=5971857

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2532377A Pending JPS52108970A (en) 1976-03-09 1977-03-08 Production of novel aminoalkyl heterocyclic compound
JP60126401A Pending JPS6172A (ja) 1976-03-09 1985-06-12 新規アミノアルキル複素環式化合物

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP60126401A Pending JPS6172A (ja) 1976-03-09 1985-06-12 新規アミノアルキル複素環式化合物

Country Status (36)

Country Link
US (4) US4154829A (ja)
JP (2) JPS52108970A (ja)
AT (1) AT360542B (ja)
AU (1) AU515953B2 (ja)
BE (1) BE852223A (ja)
BG (4) BG28051A4 (ja)
CA (1) CA1086317A (ja)
CH (8) CH630358A5 (ja)
CS (2) CS209435B2 (ja)
DD (1) DD130037A5 (ja)
DE (1) DE2609645A1 (ja)
DK (1) DK102177A (ja)
ES (10) ES456622A1 (ja)
FI (1) FI69070C (ja)
FR (2) FR2343731A1 (ja)
GB (1) GB1571231A (ja)
GR (1) GR64553B (ja)
HK (1) HK12884A (ja)
HU (1) HU177953B (ja)
IE (1) IE45300B1 (ja)
IL (1) IL51627A (ja)
LU (1) LU76898A1 (ja)
MX (1) MX4878E (ja)
MY (1) MY8500079A (ja)
NL (1) NL7702403A (ja)
NO (1) NO147950C (ja)
NZ (1) NZ183536A (ja)
PH (3) PH16110A (ja)
PL (2) PL112937B1 (ja)
PT (1) PT66282B (ja)
RO (3) RO76589A (ja)
SE (1) SE435059B (ja)
SG (1) SG55583G (ja)
SU (4) SU698530A3 (ja)
YU (1) YU62377A (ja)
ZA (1) ZA771412B (ja)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2006513222A (ja) * 2002-12-23 2006-04-20 アルテシアン セラピューティック，インコーポレイティド アドレナリン性β受容体およびホスホジエステラーゼに対する抑制活性を有する強心性化合物
JP2008521805A (ja) * 2004-11-30 2008-06-26 アーテシアン セラピューティクス， インコーポレイテッド β−アドレナリン作用性受容体およびホスホジエステラーゼに対する阻害活性を有する強心性化合物
JP2009500310A (ja) * 2005-07-01 2009-01-08 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 長時間作用性のベータ作用薬と少なくとも１種の更なる有効成分とを含む呼吸器系疾患治療用の新規な医薬組成物
JP2009263380A (ja) * 2001-04-18 2009-11-12 Euro-Celtique Sa ノシセプチン類似体
JP4785751B2 (ja) * 2004-01-09 2011-10-05 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 呼吸器疾患の治療のための３−ヒドロキシメチル−４−ヒドロキシ−フェニル誘導体

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2609645A1 (de) * 1976-03-09 1977-09-15 Boehringer Sohn Ingelheim Aminoalkylheterocyclen
DE2644833A1 (de) * 1976-10-05 1978-04-20 Boehringer Sohn Ingelheim Neue 1-aryloxy-2-hydroxy-3-alkylenaminopropane und verfahren zu ihrer herstellung
DE2833140A1 (de) * 1978-07-28 1980-02-07 Boehringer Sohn Ingelheim Neue n-substituierte heterocyclen
BE883069A (fr) 1979-05-04 1980-08-18 Continental Pharma Derives de phenylethylamine, leur preparation et utilisation ainsi que composition contenant ces derives.
DE3026534A1 (de) * 1980-07-12 1982-03-18 C.H. Boehringer Sohn, 6507 Ingelheim 3,1-benzoxazin-2-one, ihre herstellung und verwendung
US4460581A (en) * 1982-10-12 1984-07-17 Boehringer Ingelheim Kg (1-Hydroxy-2-amino-alkyl)-substituted benzoxazinones and benzoxazolinones
DE3325875A1 (de) * 1983-07-18 1985-01-31 Boehringer Ingelheim KG, 6507 Ingelheim Neue 1-phenylimidazolidin-2-on-derivate, ihre herstellung und verwendung
US4743613A (en) * 1986-04-08 1988-05-10 Smithkline Beckman Corporation Ester prodrugs of dopamine-β-hydroxylase, inhibitors, composition containing them, and method of using them to inhibit dopamine-β-hydroxylase activity
GB8609331D0 (en) * 1986-04-16 1986-05-21 Pfizer Ltd Anti-arrythmia agents
TW203049B (ja) * 1990-04-13 1993-04-01 Yamanouchi Pharma Co Ltd
ZA967892B (en) * 1995-09-21 1998-03-18 Lilly Co Eli Selective β3 adrenergic agonists.
EP0827746B1 (en) 1996-09-05 2002-04-03 Eli Lilly And Company Carbazole analogues as selective beta3 adrenergic agonists
US5808080A (en) 1996-09-05 1998-09-15 Eli Lilly And Company Selective β3 adrenergic agonists
CO5011072A1 (es) * 1997-12-05 2001-02-28 Lilly Co Eli Etanolaminas pirazinil substituidas como agfonistas de los receptores
CA2443938C (en) 2001-04-18 2010-06-22 R. Richard Goehring Spiroindene and spiroindane compounds as opioid ligands useful for treating pain
BR0209128A (pt) * 2001-04-18 2005-11-01 Euro Celtique Sa Compostos, composições farmacêuticas, métodos para o tratamento de dores, métodos para a modulação de uma resposta farmacológica e usos de compostos
SI1385518T1 (sl) 2001-04-18 2009-02-28 Euro Celtique Sa Benzimidazolonske spojine
RU2299883C2 (ru) 2001-04-18 2007-05-27 Эро-Селтик, С.А. Соединения спиропиразола, содержащая их фармацевтическая композиция, способ модуляции опиоидного рецептора и способ лечения с применением таких соединений
US7056916B2 (en) 2002-11-15 2006-06-06 Boehringer Ingelheim Pharma Gmbh & Co. Kg Medicaments for the treatment of chronic obstructive pulmonary disease
WO2004050657A2 (en) * 2002-11-27 2004-06-17 Artesian Therapeutics, Inc. COMPOUNDS WITH MIXED PDE-INHIBITORY AND β-ADRENERGIC ANTAGONIST OR PARTIAL AGONIST ACTIVITY FOR TREATMENT OF HEART FAILURE
DE102004003428A1 (de) * 2004-01-23 2005-08-11 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue langwirksame Beta-2-Agonisten, und deren Verwendung als Arzneimittel
US20050272726A1 (en) * 2004-04-22 2005-12-08 Boehringer Ingelheim International Gmbh Novel medicaments for the treatment of respiratory diseases
DE102004021779A1 (de) * 2004-04-30 2005-11-24 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue Beta-Agonisten, Verfahren zu deren Herstellung und deren Verwendung als Arzneimittel
US20050255050A1 (en) * 2004-05-14 2005-11-17 Boehringer Ingelheim International Gmbh Powder formulations for inhalation, comprising enantiomerically pure beta agonists
US7220742B2 (en) 2004-05-14 2007-05-22 Boehringer Ingelheim International Gmbh Enantiomerically pure beta agonists, process for the manufacture thereof and use thereof as medicaments
US20050256115A1 (en) * 2004-05-14 2005-11-17 Boehringer Ingelheim International Gmbh Aerosol formulation for the inhalation of beta-agonists
DE102004045648A1 (de) * 2004-09-21 2006-03-23 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue Betamimetika zur Behandlung von Atemwegserkrankungen
US20080090827A1 (en) * 2004-11-30 2008-04-17 Artesian Therapeutics, Inc. Compounds With Mixed Pde-Inhibitory and Beta-Adrenergic Antagonist or Partial Agonist Activity For Treatment of Heart Failure
DE102005007654A1 (de) * 2005-02-19 2006-08-24 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue langwirksame Betamimetika zur Behandlung von Atemwegserkrankungen
JP5270343B2 (ja) * 2005-08-15 2013-08-21 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング ベータミメティックスの製造方法
DE102005052102A1 (de) * 2005-10-28 2007-05-03 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue Beta-Agonisten, Verfahren zu deren Herstellung und deren Verwendung als Arzneimittel
DE102005052101A1 (de) * 2005-10-28 2007-05-03 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue Beta-Agonisten, Verfahren zu deren Herstellung und deren Verwendung als Arzneimittel
DE102005052127A1 (de) * 2005-10-28 2007-05-03 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue indol-haltige Beta-Agonisten, Verfahren zu deren Herstellung und deren Verwendung als Arzneimittel
EP1986644A1 (de) * 2006-02-16 2008-11-05 Boehringer Ingelheim International GmbH Arzneimittelkombinationen zur behandlung von atemwegserkrankungen
PE20080142A1 (es) 2006-03-15 2008-04-14 Boehringer Ingelheim Int Beta-agonistas enantiomericamente puros y sus procedimientos de preparacion
DE502007006951D1 (de) 2006-08-07 2011-05-26 Boehringer Ingelheim Pharma Arzneimittelkombinationen zur behandlung von atemwegserkrankungen
US9604926B2 (en) 2007-08-16 2017-03-28 The University Of Mississippi Highly selective sigma receptor radioligands
US8686008B2 (en) * 2007-08-16 2014-04-01 The University Of Mississippi Highly selective sigma receptor ligands
US8809381B2 (en) * 2007-08-16 2014-08-19 The University Of Mississippi Highly selective sigma receptor ligands

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA631296A (en) * 1961-11-21 L. Clark Robert Substituted benzimidazolones
CH149009A (de) * 1929-08-10 1931-08-15 Chem Ind Basel Verfahren zur Darstellung einer N-substituierten Verbindung der Pyridonreihe.
US2857394A (en) * 1957-05-10 1958-10-21 Ciba Pharm Prod Inc Heterocyclic compounds
NL284529A (ja) * 1961-10-24
FR1516714A (fr) * 1962-11-07 1968-02-05 Bayer Ag Procédé de préparation de dérivés de l'imidazolidine
FR1384708A (fr) * 1963-11-21 1965-01-08 Thomson Houston Comp Francaise Perfectionnements aux dispositifs de mise en place d'objets
BE659364A (ja) * 1964-02-05
US3355457A (en) * 1965-05-21 1967-11-28 American Cyanamid Co Substituted 2-imidazolinones
FR1573739A (ja) * 1968-07-26 1969-07-04
US3984405A (en) * 1971-06-28 1976-10-05 E. R. Squibb & Sons, Inc. Anti-inflammatory agents
BE787103A (fr) * 1971-08-04 1973-02-02 Pfizer Nouveaux derives de propanolamine et composition pharmaceutiqueles contenant
FR2168140A1 (en) * 1972-01-17 1973-08-31 Bellon Labor Sa Roger Dihydro-benzoxazine derivs - antidepressants
US3925383A (en) * 1972-12-08 1975-12-09 Janssen Pharmaceutica Nv Bicyclic imidazoles and pyrimidines
US3994901A (en) * 1974-06-13 1976-11-30 Otsuka Pharmaceutical Company Limited 5-[1-Hydroxy-2-(substituted-amino)]alkyl-8-hydroxy-3,4-dihydrocarbostyril derivatives
US4081447A (en) * 1975-04-09 1978-03-28 Abbott Laboratories 5-[2-Hydroxy-3-(3,4-dimethoxy phenethylamino)]-propoxy-3,4-dihydro carbostyril and pharmaceutically acceptable salts thereof
DE2609645A1 (de) * 1976-03-09 1977-09-15 Boehringer Sohn Ingelheim Aminoalkylheterocyclen

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2009263380A (ja) * 2001-04-18 2009-11-12 Euro-Celtique Sa ノシセプチン類似体
JP2006513222A (ja) * 2002-12-23 2006-04-20 アルテシアン セラピューティック，インコーポレイティド アドレナリン性β受容体およびホスホジエステラーゼに対する抑制活性を有する強心性化合物
JP4785751B2 (ja) * 2004-01-09 2011-10-05 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 呼吸器疾患の治療のための３−ヒドロキシメチル−４−ヒドロキシ−フェニル誘導体
JP2008521805A (ja) * 2004-11-30 2008-06-26 アーテシアン セラピューティクス， インコーポレイテッド β−アドレナリン作用性受容体およびホスホジエステラーゼに対する阻害活性を有する強心性化合物
JP2009500310A (ja) * 2005-07-01 2009-01-08 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 長時間作用性のベータ作用薬と少なくとも１種の更なる有効成分とを含む呼吸器系疾患治療用の新規な医薬組成物

Also Published As

Publication number Publication date
YU62377A (en) 1982-10-31
DD130037A5 (de) 1978-03-01
ES456622A1 (es) 1978-03-16
IE45300B1 (en) 1982-07-28
ES466606A1 (es) 1978-10-01
SU685149A3 (ru) 1979-09-05
CH630363A5 (de) 1982-06-15
FR2372810B1 (ja) 1982-11-26
FR2343731A1 (fr) 1977-10-07
CH630364A5 (de) 1982-06-15
SE435059B (sv) 1984-09-03
NO770804L (no) 1977-09-12
FI69070B (fi) 1985-08-30
ES466598A1 (es) 1978-10-01
US4363814A (en) 1982-12-14
DK102177A (da) 1977-09-10
ES466601A1 (es) 1978-10-01
IL51627A0 (en) 1977-05-31
ES466604A1 (es) 1978-10-01
PL112937B1 (en) 1980-11-29
PH17635A (en) 1984-10-18
PH16149A (en) 1983-07-12
PT66282A (pt) 1977-04-01
NO147950B (no) 1983-04-05
CH630359A5 (de) 1982-06-15
NL7702403A (nl) 1977-09-13
PL111240B1 (en) 1980-08-30
SU698530A3 (ru) 1979-11-15
BG28051A4 (en) 1980-02-25
CH630358A5 (de) 1982-06-15
BG28053A4 (en) 1980-02-25
MX4878E (es) 1982-11-26
CH630361A5 (de) 1982-06-15
DE2609645A1 (de) 1977-09-15
BE852223A (fr) 1977-09-08
JPS6172A (ja) 1986-01-06
PL196505A1 (pl) 1979-06-18
AU2300977A (en) 1978-09-14
US4215119A (en) 1980-07-29
NZ183536A (en) 1981-11-19
MY8500079A (en) 1985-12-31
ZA771412B (en) 1978-11-29
CH630360A5 (de) 1982-06-15
SE7702609L (sv) 1977-10-11
ATA122377A (de) 1980-06-15
PH16110A (en) 1983-06-30
CH630365A5 (de) 1982-06-15
US4271158A (en) 1981-06-02
FI69070C (fi) 1985-12-10
BG28052A4 (en) 1980-02-25
HK12884A (en) 1984-02-24
FR2372810A1 (fr) 1978-06-30
US4154829A (en) 1979-05-15
GR64553B (en) 1980-04-14
FR2343731B1 (ja) 1982-02-26
IE45300L (en) 1977-09-09
CA1086317A (en) 1980-09-23
ES466602A1 (es) 1978-10-01
SU676163A3 (ru) 1979-07-25
CH630362A5 (de) 1982-06-15
ES466600A1 (es) 1978-10-01
NO147950C (no) 1983-07-13
AU515953B2 (en) 1981-05-14
GB1571231A (en) 1980-07-09
RO79706A (ro) 1982-08-17
BG27743A3 (en) 1979-12-12
RO76589A (ro) 1981-04-30
AT360542B (de) 1981-01-12
HU177953B (en) 1982-02-28
SU683616A3 (ru) 1979-08-30
ES466603A1 (es) 1978-10-01
ES466599A1 (es) 1978-10-01
PT66282B (pt) 1979-01-17
IL51627A (en) 1980-10-26
CS220320B2 (en) 1983-03-25
CS209435B2 (en) 1981-12-31
ES466605A1 (es) 1978-10-01
RO70569A (ro) 1981-11-24
FI770586A (ja) 1977-09-10
LU76898A1 (ja) 1978-06-01
SG55583G (en) 1984-07-27

Similar Documents

Publication Publication Date Title
JPS52108970A (en) Production of novel aminoalkyl heterocyclic compound
JPS5315493A (en) Production of androstann177 one derivative
JPS55149349A (en) Production of novel substituted nitroaminophenol
JPS5353690A (en) Production of antiibacterial compound
ZA794910B (en) Production of heterocyclic compounds
JPS5312894A (en) Production of pyrazoloquinazolinone derivative
JPS5340771A (en) Novel polymorph of heterocyclic compound
JPS5265296A (en) Novel heterocyclic compound
JPS537680A (en) Production of 6a*10aatranss hexahydrobenzopyranone derivatives
JPS52128347A (en) Production of polyiodobenzene derivatives
JPS51122094A (en) Production of heterocyclic compound
JPS52113967A (en) Production of aromatic methyleneedioxy compound
JPS5289668A (en) Production of heterocyclic compound
JPS525788A (en) Production of cephlosporin compound
JPS52131594A (en) Production of nnglycosyl derivative of polyenemacroride
JPS52144686A (en) Production of 33benzoazepine derivative
JPS5325571A (en) Production of thiochmaron derivatives
JPS5318585A (en) Production of 55fluoruracil derivatives
JPS5359093A (en) Novel production of lypase
JPS52105242A (en) Production of instant sekihan
JPS5344577A (en) Production of novel cinconinethioamide derivatives
JPS539797A (en) Production of pyrazolopyridotriazolopirimidine derivative
JPS5321174A (en) Production of 44phenylpiperidine derivatives
JPS5287161A (en) Production of novel heterocyclic compound
JPS5344582A (en) Production of boron containing heterocyclic compound